suggests

The antimalarial drug hydroxychloroquine. /VCG The antimalarial drug hydroxychloroquine. /VCG The antimalarial drug hydroxychloroquine, which was touted by U.S. President Donald Trump, was found effective in treating COVID-19 patients by a new study after many others said no.The study, led by a research team from Henry Ford Health System in southeast Michigan, U.S., was published…

June 26, 2020Updated 4:13 p.m. ETIn a study not yet published in a journal, scientists have reported that the new coronavirus was present in wastewater in Barcelona, Spain in March 2019, a finding that, if confirmed, would show that the pathogen had emerged much earlier than previously thought.But independent experts who reviewed the findings said…

Temperature checks, desk shields and no public transit: The guidelines would remake office life. Some may decide it’s easier to keep employees at home.Offices at the University of California, Irvine’s infection prevention division last month, which has installed sneeze guards separating cubicles and encourages mask-wearing and hand-sanitizing.Credit...Alex Welsh for The New York TimesMay 28, 2020Updated…

May 17, 2020 | 8:51am | Updated May 17, 2020 | 10:05am Enlarge Image Wuhan residents receive nucleic acid tests Getty Images A study found the coronavirus was taken to an animal market in Wuhan, China, by a person already infected with the disease, according to a report. “The publicly available genetic data does not…

Share on PinterestThe presence of the protein suPAR in a person’s blood may help researchers pinpoint who is at higher risk of severe COVID-19.A new study suggests that the protein soluble urokinase plasminogen activator receptor (suPAR) may help scientists predict who is likely to develop more severe COVID-19.The research, published as a research letter in…